2013-08-27 16:04:03 -
Current General Counsel and Corporate Secretary Christopher L. Gaenzle
to assume new leadership role; move demonstrates Company's enhanced
focus on support areas of the organization essential to success
Raleigh, N.C., Aug. 27, 2013 - INC Research LLC, a therapeutically focused
global clinical research organization (CRO) with a Trusted Process® for
delivering reliable results, today announced the appointment of Christopher L.
Gaenzle to the newly created role of Chief Administrative Officer (CAO), further
rounding out the Company's executive leadership team. The creation of the CAO
role is designed to enhance INC's focus on key initiatives related to the
development and deployment of a best-in-class workforce, supporting the
Company's strategy for continued growth and expansion as a top-tier CRO.
Gaenzle, who joined INC Research in April 2012 as General Counsel and Corporate
Secretary, will continue to serve in this capacity in addition to assuming the
CAO role, through which he will provide global leadership for such key functions
as Human Resources, Training and Corporate Quality.
"As we move forward and position INC Research to compete for the larger
strategic outsourcing opportunities, our infrastructure and ability to deliver
on a global scale have never been more important," said CEO Jamie Macdonald.
"The creation of the CAO role provides an enhanced focus on the support areas of
our organization essential to our future success. We look forward to Chris'
leadership as we continue to drive growth and meet the strategic outsourcing
needs of our customers worldwide."
As General Counsel for INC Research, Mr. Gaenzle has been responsible for the
Company's legal affairs for the U.S. and internationally, and advises the Board
of Directors, the CEO and the executive team on legal matters. In addition, Mr.
Gaenzle oversees INC's Corporate Quality and compliance functions. With the
addition of the CAO role, he also will provide overall leadership for the Human
Resources, Training and Facilities functions. Mr. Gaenzle has nearly 20 years
of private practice and corporate legal experience, the majority in the
pharmaceutical, medical and clinical research industries. Prior to joining INC
he was Assistant General Counsel at Pfizer Inc. He brings to the CAO role
valuable experience gained at Pfizer where his responsibilities included
operational support and talent management at a functional level.
The creation of the CAO role and the appointment of Mr. Gaenzle complement other
executive leadership moves at INC Research in recent months, including the
appointments of Greg Rush as Executive Vice President and CFO and Ian
Braithwaite, PhD, as Executive Vice President and General Manager, General
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to us for a complete range of customized Phase I to IV programs in
all therapeutic areas and patient populations. Our Trusted Process® methodology
and therapeutic foresight lead customers to better-informed product development
decisions, while our solid site relationships are a critical success factor in
delivering clinical trial results on time and on budget. INC was ranked "Top
CRO" by sites worldwide in the 2013 CenterWatch Global Investigative Site
Relationship Survey. INC Research is headquartered in Raleigh, NC. For more
information, please visit www.incresearch.com or follow us at @inc_research.
Contact: Lori Dorer, Media +1 (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE